Experts in plasminogen research
We develop disruptive treatments that improve lives while lowering the overall cost of health care with plasminogen-based therapeutics. Unlike other products available on the market, plasminogen has been shown to be a key regulatory molecule that activates all stages of the wound healing process.
Omino is led by a team of life science entrepreneurs with extensive experience in immunology, partnerships and drug discovery collaborations.
Omnio is developing recombinant plasminogen for treatment of chronic wounds.
The management of chronic wounds is an enormous clinical and economic burden on the health care system.
Clinical development plan
We focus on delivering transformative treatment for chronic wounds and where there is little to no pharmacologically active treatment available today.